If you’ve been following the news about the Medicare GLP-1 Bridge Program, you’re probably asking one question above all others: “Do I qualify?” The answer isn’t always straightforward. Eligibility depends on your Medicare coverage, your...
If you’ve heard about Zepbound® (tirzepatide) and are wondering whether Medicare will help pay for it in 2026, you’re not alone. Millions of older Americans struggle with obesity and its complications, including heart disease, sleep apnea, arthritis, high...
If you’ve heard about Medicare’s new GLP-1 Bridge Program, you may be wondering: “Will Medicare pay for Wegovy® in 2026?” The short answer is yes—but it depends on why you’re taking Wegovy and whether you meet the program’s...
The Health Benefits of GLP-1 Medications: More Than Weight Loss GLP-1 medications have transformed the treatment of obesity and Type 2 diabetes. While many people first hear about these medications because of their impressive weight-loss results, research has shown...
For many people, GLP-1 medications are known simply as “weight-loss injections.” While weight reduction is certainly an important benefit, research over the last several years has revealed something much more remarkable. Scientists now recognize that GLP-1...
For many years, obesity was viewed simply as a matter of willpower. Today, medical research tells a different story. Obesity is now recognized as a complex, chronic disease influenced by genetics, hormones, metabolism, and environmental factors. One of the most...
